- Home
- CTRN vs ALDX Comparison
CTRN vs ALDX Comparison
Compare CTRN & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | ALDX |
|---|---|---|
| Founded | 1946 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.7M | 293.0M |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CTRN | ALDX |
|---|---|---|
| Price | $41.86 | $4.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $52.00 | $9.50 |
| AVG Volume (30 Days) | 121.2K | ★ 1.6M |
| Earning Date | 12-02-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,741,000.00 | N/A |
| Revenue This Year | $8.16 | N/A |
| Revenue Next Year | $5.38 | $36.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.77 | N/A |
| 52 Week Low | $16.82 | $1.14 |
| 52 Week High | $49.50 | $7.20 |
Technical Indicators
Market Signals| Indicator | CTRN | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 49.88 |
| Support Level | $42.73 | $3.94 |
| Resistance Level | $48.49 | $5.68 |
| Average True Range (ATR) | 2.74 | 0.42 |
| MACD | -0.64 | 0.03 |
| Stochastic Oscillator | 33.65 | 57.93 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.